Skip to main content
Q

QuantaMatrix Incorporated — Investor Relations & Filings

Ticker · 317690 ISIN · KR7317690006 KO Manufacturing
Open in API
Filings indexed 155 across all filing types
Latest filing 2026-04-01 Major Shareholding Noti…
Country KR South Korea
Listing KO 317690

About QuantaMatrix Incorporated

https://www.quantamatrix.com/

QuantaMatrix Incorporated is an in-vitro diagnostics (IVD) company specializing in the development and manufacturing of medical devices using microbial diagnostics technology. The company focuses on providing rapid diagnostic solutions for critical conditions, with a primary emphasis on sepsis. Its flagship product, dRAST™ (direct & Rapid Antimicrobial Susceptibility Test), significantly reduces the time for determining effective antibiotics for sepsis patients, providing results in as few as four hours from a positive blood culture, compared to several days for conventional methods. This technology, which utilizes microfluidic channels and time-lapse microscopic imaging, enables faster, targeted antimicrobial therapy. In addition to sepsis, QuantaMatrix develops diagnostic solutions for other areas, including tuberculosis (QDST™), Alzheimer's disease (QPLEX™), and cardiovascular diseases.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 94% confidence The document is a ‘주식등의 대량보유상황보고서’ filed under Korea’s Capital Markets Act (reporting large shareholding by insiders and related parties). It contains detailed tables of share quantities, ownership percentages, changes in holdings, special relationships, and contractual arrangements. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled “정기주주총회 결과” (Regular Shareholders’ Meeting Results) and provides detailed voting outcomes for each resolution (approval of financial statements, director elections, amendment of articles, remuneration caps, etc.), including vote counts and percentages. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (DVA), which covers official vote results at shareholder meetings. Thus, the correct classification is DVA.
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 91% confidence The document is a formal disclosure submitted to the Financial Services Commission and Korea Exchange detailing the appointment (신규선임) and status changes of outside directors (사외이사) at 주식회사 퀀타매트릭스. It lists dates, names, positions, and past experience of the newly appointed outside director, which is precisely an announcement of changes in the company’s board of directors. This matches the Board/Management Information category.
2026-03-31 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 16th fiscal year (2025) of QuantaMatrix. It contains comprehensive financial information, business descriptions, management details, and operational data, which is the standard format for an Annual Report (10-K equivalent in the Korean market). It is not a mere announcement or a short summary, but the full report itself. FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 92% confidence The document is a Korean-language “감사보고서 제출” notice containing consolidated and standalone audit opinions (“감사의견: 적정”) for the fiscal periods, key financial statement figures, auditor name, and details about the audit report receipt date. It is not a full annual report or earnings release but a standalone audit report submission. According to the filing definitions, this corresponds to an Audit Report / Information (Code: AR). FY 2025
2026-03-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (Quantamatrix) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audit report is finalized. Since it provides key financial highlights and performance metrics for the fiscal year, it falls under the 'Earnings Release' category. FY 2025
2026-03-16 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.